Inflammatory bowel disease and risk of Parkinson's disease in Medicare beneficiaries
Document Type
Article
Abstract
INTRODUCTION: Gastrointestinal (GI) dysfunction precedes the motor symptoms of Parkinson's disease (PD) by several years. PD patients have abnormal aggregation of intestinal α-synuclein, the accumulation of which may be promoted by inflammation. The relationship between intestinal α-synuclein aggregates and central nervous system neuropathology is unknown. Recently, we observed a possible inverse association between inflammatory bowel disease (IBD) and PD as part of a predictive model of PD. Therefore, the objective of this study was to examine the relationship between PD risk and IBD and IBD-associated conditions and treatment. METHODS: Using a case-control design, we identified 89,790 newly diagnosed PD cases and 118,095 population-based controls >65 years of age using comprehensive Medicare data from 2004-2009 including detailed claims data. We classified IBD using International Classification of Diseases version 9 (ICD-9) diagnosis codes. We used logistic regression to calculate odds ratios (ORs) and 95% confidence intervals (CIs) to evaluate the association between PD and IBD. Covariates included age, sex, race/ethnicity, smoking, Elixhauser comorbidities, and health care use. RESULTS: PD was inversely associated with IBD overall (OR = 0.85, 95% CI 0.80-0.91) and with both Crohn's disease (OR = 0.83, 95% CI 0.74-0.93) and ulcerative colitis (OR = 0.88, 95% CI 0.82-0.96). Among beneficiaries with ≥2 ICD-9 codes for IBD, there was an inverse dose-response association between number of IBD ICD-9 codes, as a potential proxy for IBD severity, and PD (p-for-trend = 0.006). CONCLUSION: IBD is associated with a lower risk of developing PD.
Medical Subject Headings
Aged; Aged, 80 and over; Case-Control Studies; Colitis, Ulcerative (epidemiology, therapy); Crohn Disease (epidemiology, therapy); Digestive System Surgical Procedures (statistics & numerical data); Female; Humans; Immunosuppressive Agents (therapeutic use); Inflammatory Bowel Diseases (epidemiology, therapy); Male; Medicare (statistics & numerical data); Parkinson Disease (epidemiology); Prodromal Symptoms; Risk; United States (epidemiology)
Publication Date
5-1-2018
Publication Title
Parkinsonism & related disorders
E-ISSN
1873-5126
Volume
50
First Page
23
Last Page
28
PubMed ID
29459115
Digital Object Identifier (DOI)
10.1016/j.parkreldis.2018.02.008
Recommended Citation
Camacho-Soto, Alejandra; Gross, Anat; Searles Nielsen, Susan; Dey, Neelendu; and Racette, Brad A., "Inflammatory bowel disease and risk of Parkinson's disease in Medicare beneficiaries" (2018). Neurology. 1140.
https://scholar.barrowneuro.org/neurology/1140